Cold Agglutinin Disease Clinical Trials

19 clinical trials for Cold Agglutinin Disease across international registries, including 3 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Prospective Evaluation of Diagnosis and Treatment of Patients With Autoimmune Cytopenias Including Autoimmune Hemolytic Anemia, Immune Thrombocytopenia, and Chronic Idiopathic/Autoimmune Neutropenia — RECRUITING
• A MULTICENTER, PHASE 1B, OPEN LABEL, NONRANDOMIZED, SINGLE DOSE STUDY EVALUATING THE SAFETY, TOLERABILITY AND ACTIVITY OF BIVV020 IN ADULTS WITH COLD AGGLUTININ DISEASE — RECRUITING · PHASE1
• A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE EFFICACY AND SAFETY OF BIVV009 IN PATIENTS WITH PRIMARY COLD AGGLUTININ DISEASE WITHOUT A RECENT HISTORY OF BLOOD TRANSFUSION — RECRUITING · PHASE3
• HOVON 169 CAD: Phase II trial of Zanubrutinib in primary Cold Agglutinin Disease. CaZa study — TERMINATED · PHASE2
• An Open-label Study of Povetacicept in Participants With Autoimmune Cytopenias — ACTIVE_NOT_RECRUITING · PHASE1
• Cold Agglutinin Disease Real World Evidence Registry — ACTIVE_NOT_RECRUITING
• A Study to Evaluate the Efficacy and Safety of Pegcetacoplan in Patients With Cold Agglutinin Disease (CAD) — COMPLETED · PHASE3
• Basket Study to Assess Efficacy, Safety and PK of Iptacopan (LNP023) in Autoimmune Benign Hematological Disorders — TERMINATED · PHASE2
• Sutimlimab (BIVV009) for the Adult Participants With Cold Agglutinin Disease (CAD) Who Have Completed Phase 3 Studies (CARDINAL or CADENZA) in Japan — COMPLETED · PHASE3
• Study to Assess the Safety, Tolerability, Efficacy and PK of APL-2 in Patients With Warm Type Autoimmune Hemolytic Anemia (wAIHA) or Cold Agglutinin Disease (CAD) — COMPLETED · PHASE2
• A Study to Assess the Efficacy and Safety of BIVV009 (Sutimlimab) in Participants With Primary Cold Agglutinin Disease Without A Recent History of Blood Transfusion — COMPLETED · PHASE3
• A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED MULTICENTER STUDY TO EVALUATE THE EFFICACY AND SAFETY OF PEGCETACOPLAN IN PATIENTS WITH COLD AGGLUTININ DISEASE (CAD) — COMPLETED · PHASE3
• Safety, Tolerability and Activity of BIVV009 in Healthy Volunteers and Patients With Complement Mediated Disorders — COMPLETED · PHASE1
• AN OPEN LABEL, LONG TERM, SAFETY AND TOLERABILITY STUDY OF PATIENTS WITH COLD AGGLUTININ DISEASE PREVIOUSLY TREATED WITH BIVV020 — NOT_YET_RECRUITING
• A PIVOTAL, OPEN-LABEL, MULTICENTER STUDY TO ASSESS THE EFFICACY AND SAFETY OF BIVV009 IN PATIENTS WITH PRIMARY COLD AGGLUTININ DISEASE WHO HAVE A RECENT HISTORY OF BLOOD TRANSFUSION — COMPLETED
• Therapy of Chronic Cold Agglutinin Disease With Eculizumab — COMPLETED · PHASE2
• Bendamustine and Rituximab Combination Therapy for Cold Agglutinin Disease — COMPLETED · PHASE2
• The RITAI Cohort: An Observational Study on Rituximab Off-label Use for Auto-immune Disorders — COMPLETED
• Therapy for Chronic Cold Agglutinin Disease — COMPLETED · PHASE2

Refine this search